Compile Data Set for Download or QSAR
maximum 50k data
Found 44 Enz. Inhib. hit(s) with Target = 'Dual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D]'
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337926((R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1711(CHEMBL1684067 | US8470837, 8)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337929((S)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337932(5-(2-fluoro-4-iodophenylamino)-3-(2-hydroxyethyl)-...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97644(US8470837, 12)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337928((R)-3-(2,3-dihydroxypropyl)-5-(4-ethynyl-2-fluorop...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337933(3-(1,3-dihydroxypropan-2-yl)-6-fluoro-5-(2-fluoro-...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337937(5-(2-fluoro-4-iodophenylamino)-3-(3-hydroxypropyl)...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1714(CHEMBL1684071 | US8470837, 13)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97651(US8470837, 30)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337934((R)-3-(2,3-dihydroxypropoxy)-6-fluoro-5-(2-fluoro-...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337920((R)-3-(2,3-dihydroxypropyl)-5-(2-fluoro-4-iodophen...)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97641(US8470837, 7)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97652(US8470837, 32)
Affinity DataIC50: <5nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97646(US8470837, 16)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1722(US8470837, 41)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1717(US8470837, 21)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1716(CHEMBL1684072 | US8470837, 17)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97662(US8470837, 4)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1665(CHEMBL1684061 | US8470837, 2)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1710(CHEMBL1684064 | US8470837, 5)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97661(US8470837, 44)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97660(US8470837, 43)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97658(US8470837, 40)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97654(US8470837, 34)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97650(US8470837, 29)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97649(US8470837, 27)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97648(US8470837, 26)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97647(US8470837, 24)
Affinity DataIC50:  10nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337935(5-(2-fluoro-4-iodophenylamino)-3,8-dimethylpyrido[...)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97645(US8470837, 15)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1713(US8470837, 9)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97653(US8470837, 33)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97659(US8470837, 42)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97655(US8470837, 35)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337922((S)-3-(2,4-dihydroxybutyl)-5-(2-fluoro-4-iodopheny...)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97640(US8470837, 3)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97657(US8470837, 38)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337923(3-(2-(dimethylamino)ethyl)-5-(2-fluoro-4-iodopheny...)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97642(US8470837, 10)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97656(US8470837, 36)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97643(US8470837, 11)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337927((R)-5-(4-bromo-2-fluorophenylamino)-3-(2,3-dihydro...)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM1719(US8470837, 23)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent